{"title":"生物金融和准入委员会第二次年度生物制剂医疗保健调查:主要医疗保健利益相关者的观点，第2部分。","authors":"David B Nash, Michael Toscani, F Randy Vogenberg","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Part 2 of BFAC's survey reveals a range of understanding among providers, purchasers, and payers about the management of biologics and the implications of their use.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"23-5"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278121/pdf/bh0803023.pdf","citationCount":"0","resultStr":"{\"title\":\"The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2.\",\"authors\":\"David B Nash, Michael Toscani, F Randy Vogenberg\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Part 2 of BFAC's survey reveals a range of understanding among providers, purchasers, and payers about the management of biologics and the implications of their use.</p>\",\"PeriodicalId\":89534,\"journal\":{\"name\":\"Biotechnology healthcare\",\"volume\":\"8 3\",\"pages\":\"23-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278121/pdf/bh0803023.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology healthcare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2.
Part 2 of BFAC's survey reveals a range of understanding among providers, purchasers, and payers about the management of biologics and the implications of their use.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
